Code of conduct of the European Medicines Agency
Submitted by Anonymous (not verified) on 19 June 2025 - 9:47
Code of conduct of the European Medicines Agency
EMA’s 30th anniversary scientific conference - Medicines, regulation and the future, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 June 2025, 10:00 (CEST) to 25 June 2025, 16:00 (CEST)
Submitted by Anonymous (not verified) on 19 June 2025 - 9:40
EMA’s 30th anniversary scientific conference - Medicines, regulation and the future, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 June 2025, 10:00 (CEST) to 25 June 2025, 16:00 (CEST)
Agenda - EMA’s 30th anniversary scientific conference
Submitted by Anonymous (not verified) on 19 June 2025 - 9:37
Agenda - EMA’s 30th anniversary scientific conference
Epidemiological data on blood transmissible infections - Scientific guideline
Submitted by Anonymous (not verified) on 19 June 2025 - 8:50
Epidemiological data on blood transmissible infections - Scientific guideline
Draft chapter 9 of guideline on epidemiological data on blood transmissible infections
Submitted by Anonymous (not verified) on 19 June 2025 - 8:44
Draft chapter 9 of guideline on epidemiological data on blood transmissible infections
Union Product Database (UPD) - Quick guide for UPD notifications via the user interface and via email
Submitted by Anonymous (not verified) on 19 June 2025 - 8:25
Union Product Database (UPD) - Quick guide for UPD notifications via the user interface and via email
Superseded Community herbal monograph on Zingiber officinale Roscoe, rhizoma
Submitted by Anonymous (not verified) on 19 June 2025 - 1:00
Superseded Community herbal monograph on Zingiber officinale Roscoe, rhizoma
Herbal medicinal product: Vitis viniferae folium, Vitis vinifera L., C: ongoing call for scientific data
Submitted by Anonymous (not verified) on 18 June 2025 - 16:30
Herbal medicinal product: Vitis viniferae folium, Vitis vinifera L., C: ongoing call for scientific data
Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 7, Status: Authorised
Submitted by Anonymous (not verified) on 18 June 2025 - 16:20
Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Pergoveris, follitropin alfa,lutropin alfa, Date of authorisation: 25/06/2007, Revision: 17, Status: Authorised
Submitted by Anonymous (not verified) on 18 June 2025 - 16:18
Human medicines European public assessment report (EPAR): Pergoveris, follitropin alfa,lutropin alfa, Date of authorisation: 25/06/2007, Revision: 17, Status: Authorised